UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 86 filers reported holding UROGEN PHARMA LTD in Q2 2019. The put-call ratio across all filers is 0.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $376,355 | +78.2% | 26,864 | +31.6% | 0.00% | – |
| Q2 2023 | $211,202 | +4.6% | 20,406 | -11.9% | 0.00% | – |
| Q1 2022 | $202,000 | -11.8% | 23,152 | -3.8% | 0.00% | – |
| Q4 2021 | $229,000 | -44.3% | 24,064 | -1.4% | 0.00% | -100.0% |
| Q3 2021 | $411,000 | +12.6% | 24,408 | +2.1% | 0.00% | – |
| Q2 2021 | $365,000 | -29.5% | 23,903 | -10.1% | 0.00% | -100.0% |
| Q1 2021 | $518,000 | +0.4% | 26,578 | -7.2% | 0.00% | 0.0% |
| Q4 2020 | $516,000 | +4.9% | 28,648 | +12.3% | 0.00% | 0.0% |
| Q3 2020 | $492,000 | -35.3% | 25,517 | -12.3% | 0.00% | 0.0% |
| Q2 2020 | $760,000 | +81.0% | 29,087 | +23.5% | 0.00% | 0.0% |
| Q1 2020 | $420,000 | -46.2% | 23,548 | +0.6% | 0.00% | 0.0% |
| Q4 2019 | $781,000 | +49.0% | 23,405 | +6.3% | 0.00% | 0.0% |
| Q3 2019 | $524,000 | -30.9% | 22,010 | +4.4% | 0.00% | 0.0% |
| Q2 2019 | $758,000 | – | 21,079 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 1,252,285 | $24,156,000 | 7.72% |
| Horton Capital Management, LLC | 375,428 | $7,242,000 | 6.96% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,954,699 | $56,996,000 | 1.27% |
| Phoenix Holdings Ltd. | 901,979 | $16,405,000 | 0.69% |
| SHIKIAR ASSET MANAGEMENT INC | 44,550 | $859,000 | 0.33% |
| Coastal Bridge Advisors, LLC | 37,000 | $714,000 | 0.22% |
| Migdal Insurance & Financial Holdings Ltd. | 738,302 | $14,242,000 | 0.20% |
| Clal Insurance Enterprises Holdings Ltd | 529,388 | $10,212,000 | 0.17% |
| Vivaldi Capital Management LP | 10,000 | $233,000 | 0.05% |
| MEITAV INVESTMENT HOUSE LTD | 48,407 | $934,000 | 0.05% |